Tonix Pharmaceuticals Receives Fast Track Designation from the U.S. FDA for TNX-102 SL for Treatment of Agitation in Alzheimer's Disease
Stock Information for Tonix Pharmaceuticals Holding Corp.
Loading
Please wait while we load your information from QuoteMedia.